Abstract:OBJECTIVE To assess the effects of high-fat meal on the pharmacokinetic(PK) and pharmacodynamic(PD) properties and safety profile of aranidipine(AR) and its active metabolite,hydroxyl-aranidipine(AR-M1),in health Chinese subjects.METHODS One single-dose,open-label,randomized,crossover study of oral aranidipine enteric-coated capsule was conducted in healthy Chinese subjects.Twelve healthy nonsmoking subjects(6 males,6 females) aged from 18 to 45 years were orally administrated aranidipine enteric-coated capsule 10 mg in fasted state.After a washout period of 1 week,the subjects were orally administrated aranidipine enteric-coated capsule 10 mg after high-fat breakfast.Plasma samples were collected previous to the administration as well as at indicated time points after the administration.Concentrations of AR and AR-M1 in plasma were determined by HPLC-MS/MS.PK parameters(AUC0-t,AUC0-∞,ρmax,tmax,t1/2,Ke,CL/F,Vd/F,etc.) of AR and AR-M1 were calculated with DAS 2.1.1.Systolic and diastolic blood pressure(SBP and DBP) and heart rate(HR) were measured before and at indicated time points after the administration.Safety profile assessment was performed throughout the experiment.RESULTS There was significant increase in AUC0-t,AUC0-∞,and tmax for AR given after high-fat meal compared with those in fasted condition(P<0.05).For AR-M1,there was extremely significant increase in tmax(P<0.01) under high-fat meal condition and no significant difference in other parameters(P>0.05).There were no significant changes in BP and HR after the administration in a high-fat meal state compared with that in fasted state.Compared with baseline,there was significant decrease in DBP at 8 h after the administration in both fasted and high-fat meal state(P<0.05).CONCLUSION Oral administration of aranidipine enteric-coated capsule after high-fat meal results in slow absorption and significant increase in bioavailability of AR,as well as significant delay in the generation of AR-M1.There were no significant changes in BP and HR after the administration in either fasted or high-fat meal state.No serious AEs were observed during the experiment,showing the good safety profile of the agent.There is no need to adjust the dosage in clinic application,but light-food and administration in fasted state are recommended.

Food Effects on the Human Pharmacokinetics of Rasagiline Mesylate

Safety and Effectiveness of Rasagiline in Chinese Patients with Parkinson's Disease: A Prospective, Multicenter, Non-interventional Post-marketing Study.

Effect of Food on the Pharmacokinetics of Tenofovir Amibufenamide: A Phase I, Randomized, Open-Label, Two-Period Crossover Trial in Healthy Adult Subjects

Efficacy and Safety of Rasagiline in Chinese Patients with Early Parkinson’s Disease: a Randomized, Double-Blind, Parallel, Placebo-Controlled, Fixed-Dose Study

Effects of Food and Multiple‐dose Administration on the Pharmacokinetic Properties of HR20033, a Sustained‐release Formulation of Henagliflozin and Metformin for the Treatment of Diabetes, in Healthy Chinese Volunteers

Effects of Food on Absorption of Ozagrel after Oral Administration in Healthy Volunteers

Pharmacodynamic Effects and Kinetic Disposition of Rabeprazole in Relation to CYP2C19 Genotype in Healthy Chinese Subjects1

Effect of High-Fat Food on the Pharmacokinetic Profile and Safety of SAF-189s, an ALK/ROS1 Inhibitor, in Healthy Chinese Adults

Adjunct Rasagiline to Treat Parkinson’s Disease with Motor Fluctuations: a Randomized, Double-Blind Study in China

Effect of a high‐fat meal on the relative bioavailability of HMPL‐689 in Chinese Healthy Volunteers

The Effects of Food on the Bioavailability of Fenofibrate Administered Orally in Healthy Volunteers via Sustained-Release Capsule

Effects of Food and Gender on Pharmacokinetics of Rosuvastatin in a Chinese Population Based on 4 Bioequivalence Studies

Effects of food on pharmacokinetics and safety of metformin hydrochloride tablets: A meta-analysis of pharmacokinetic, bioavailability, or bioequivalence studies

Effects of High-Fat Meal on the Pharmacokinetic and Pharmacodynamic Properties and Safety Profile of Aranidipine Enteric-Coated Capsule in Healthy Chinese Subjects

Effect of Food on Pharmacokinetics and Pharmacodynamics of Fenofibric Acid aftera Single Oral Dose of Fenofibrate Sustained-Release Capsule

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Effect of Dining on the Pharmacokinetics of Losartan

Effects on CYP2D6 by the Single Use of Ampicillin and Shuanghuanglian or Combination of Both

Effect of Eating on Pharmacokinetics of Ethanesulfonic Acid Levofloxacin Tablets

The Effect of Grapefruit Juice on the Pharmacokinetics of Tadalafil in Rats.

Effects of Differential Food Patterns on the Pharmacokinetics of Enteric‐Coated Mesalazine Tablets in the Same Cohort of Healthy Chinese Volunteers